Related Experiment Video
Updated: Mar 8, 2026
04:33
Author Spotlight: Unveiling the Connection Between Sleep Disorders and Cognitive Symptoms in Depression
Published on: April 26, 2024
1.6K
Cognitive behavioral therapy for insomnia in stable heart failure: Protocol for a randomized controlled trial
Nancy S Redeker1, Andrea K Knies1, Christopher Hollenbeak2
1Yale School of Nursing, 400 West Campus Drive, West Haven, CT 06477, United States.
Contemporary Clinical Trials
|February 5, 2017
Summary
Cognitive-behavioral therapy for insomnia (CBT-I) significantly improves sleep and daytime function in heart failure (HF) patients. This study assesses the long-term effectiveness and cost-effectiveness of CBT-I for managing insomnia in HF.
Area of Science:
- Cardiology
- Sleep Medicine
- Behavioral Science
Background:
- Chronic insomnia is linked to poor health outcomes, including heart failure (HF) and mortality.
- Previous research indicated cognitive-behavioral therapy for insomnia (CBT-I) is effective for insomnia and fatigue in HF patients.
Purpose of the Study:
- To evaluate sustained effects of group CBT-I versus HF self-management education on insomnia, sleep, daytime symptoms, function, and healthcare use in stable HF patients.
- To estimate the cost-effectiveness of CBT-I and explore its impact on event-free survival (EFS).
Main Methods:
- A randomized controlled trial (RCT) involving 200 participants in a single center, cluster-randomized design.
- Utilized wrist actigraphy, self-report, psychomotor vigilance test, and the Six Minute Walk Test for data collection.
- Employed general linear mixed models, latent transition analysis, and stochastic cost-effectiveness analysis with competing risks.
Main Results:
- Results are pending, but the study is designed to assess sustained improvements in insomnia, sleep, and functional performance.
- The cost-effectiveness and impact on event-free survival will be determined.
Conclusions:
- Findings are expected to support the integration of CBT-I into heart failure care settings.
- This research aims to facilitate the dissemination and translation of CBT-I for HF patients with comorbid insomnia.
More Related Videos
Related Concept Videos
01:19Management of Insomnia
747
The sleep cycle, an integral part of human health, consists of several stages with distinct characteristics and functions. It begins with a transition from wakefulness to sleep, known as the light sleep phase, followed by the restorative deep sleep phase, essential for physical recovery and growth. The cycle concludes with the Rapid Eye Movement (REM) phase, characterized by high brain activity and vivid dreaming. Insomnia, a prevalent sleep disorder, involves difficulty falling asleep, staying...
747
01:22Heart Failure VI: Adjunct Therapies
490
Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
490
01:30Heart Failure VII: Nursing Interventions
616
The first step in nursing management of a patient with heart failure involves thoroughly assessing the patient's medical history.Subjective Data: Obtain the patient's medical history of coronary artery disease, hypertension, myocardial infarction, and symptoms like dyspnea, orthopnea, and paroxysmal nocturnal dyspnea.Objective Data: Conduct a physical examination to identify findings such as jugular vein distention, pulmonary crackles, tachycardia, murmurs, peripheral edema, and vital signs,...
616
01:27Insomnia
561
Insomnia is a prevalent sleep disorder characterized by difficulty falling asleep, frequent awakenings during the night, and waking up too early without being able to return to sleep. People with insomnia often experience these disruptions at least three nights a week for at least one month. Chronic insomnia, which lasts for at least three months, can lead to increased anxiety, which in turn can worsen sleep difficulties, creating a cycle of sleeplessness and stress.
Multiple factors contribute...
Multiple factors contribute...
561
01:22Heart Failure Drugs: β-Blockers
1.0K
β-adrenergic antagonists, commonly known as β-blockers, block the effects of sympathetic neurotransmitters such as noradrenaline (NA) and adrenaline (ADR). They have several beneficial effects in heart failure treatment. They reduce heart rate, the force of contraction, and cardiac muscle relaxation. They also slow the atrial-ventricular conduction rate and raise the threshold for arrhythmias. The concentration of β-blockers determines their effects on bronchodilation,...
1.0K
01:30Heart Failure V: Medical Management
443
Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
443